Skip to main content

Table 1 Patients and controls characteristics

From: T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study

Clinical characteristic

COVID-19 (n = 27)

Control (n = 27)

p

Age, mean, years (SD)

54 (12)

58 (12)

0.263

Gender male, No. (%)

19 (70.4)

23 (85.2)

0.129

CVD comorbidities, No. (%)

 Hypertension

8 (29.6)

9 (33.3)

0.770

 CAD

0

0

1

 Diabetes type II

2 (7.4)

3 (11.1)

0.639

 Dyslipidemia

2 (7.4)

2 (7.4)

1

Smoking

3 (11.1)

2 (7.4)

0.639

  1. CAD coronary artery disease, COVID-19 Coronavirus disease 19, CVD cardiovascular disease, SD standard deviation